ADAMA Provides Financial Performance Estimation for the Full Year of
2025
TEL AVIV, ISRAEL and BEIJING, CHINA, January 29, 2026 – ADAMA Ltd. (the “Company”) (SZSE
000553), today provided an estimate regarding its financial performance for the full year of 2025. The
Company saw further positive impact of its “Fight Forward” strategic transformation plan, with improvements
in key financial metrics, including positive adjusted net profit and significantly reduced reported net loss.
Sales
For the full year of 2025, ADAMA is expecting to report a decline in revenues of approximately 1% to 4% in
USD compared to the full year of 2024. The decline in revenues was generally attributable to lower prices
and the Company’s decisions to optimize its portfolio and geographical presence and to pivot away from
selling some basic chemical products, as well as significant declines in Turkey in Q1. Prices remained weak
mainly due to low prices of active ingredients in light of overcapacity, as well as a high-interest-rate
environment and low commodity prices, which put pressure on distributors and farmers.
Adjusted EBITDA and Net Profit
For the full year of 2025, the Company is expecting to report an increase in adjusted EBITDA and in its
margin, in comparison to the full year of 2024. Adjusted EBITDA and its margin improved due to an increase
in the gross profit and its margin, mainly reflecting the positive impacts of lower costs due to improved
operational efficiency and lower costs of inventory sold, more than compensating for lower prices.
The Company expects to report an adjusted net profit in the range of USD 4 million to 54 million for the full
year of 2025, compared to a loss of USD 206 million for the full year of 2024. The profit was mainly due to a
higher adjusted operating profit and lower tax and financial expenses.
Adjusted net profit (loss) Estimated Full Year 2024
Full Year 2025
Net profit (loss) attributable to shareholders (USD 4-54 (206)
millions)
Earnings per share (USD) 0.0016-0.0231 (0.0885)
Net profit (loss) attributable to shareholders (RMB 25-385 (1,468)
millions)
Earnings per share (RMB) 0.0107-0.1651 (0.6302)
Adjusted Net profit excludes the impact of transitory, non-operational or non-cash items, mainly including:
i. Non-cash amortization charges in respect of transfer assets received from Syngenta related to the
2017 ChemChina-Syngenta acquisition;
ii. Non-cash amortization net charges related to intangible assets created as part of the Purchase Price
Allocation (PPA) on acquisitions, with no impact on the ongoing performance of the companies
acquired;
iii. Restructuring and advisory costs incurred as part of the continued implementation of the Fight
Forward transformation plan;
iv. Fixed asset and inventory impairments related to improvement of operational efficiency, as part of
the Fight Forward plan;
v. Provision of cleanup and remediation costs by an indirectly wholly owned subsidiary of the Company
for its plant in Israel;
vi. Compensation related to product liability;
vii. Financial expenses including non-cash expenses related to revaluation of put options attributed to
minority stakes in subsidiaries.
Reported EBITDA and Net Loss
The Company expects a higher reported EBITDA and its margin and a lower reported net loss (which
includes the impact of the above adjusted items) for the full year of 2025 compared to 2024. This expectation
is mainly due to higher reported operating profit and lower tax expenses despite an increase in reported
financial expenses.
Reported net profit (loss) Estimated Full Year 2024
Full Year 2025
Net profit (loss) attributable to shareholders (USD (172)-(122) (407)
millions)
Earnings per share (USD) (0.0737)-(0.0522) (0.1749)
Net profit (loss) attributable to shareholders (RMB (1,233)-(873) (2,903)
millions)
Earnings per share (RMB) (0.5290)-(0.3746) (1.2461)
The estimated results of the Company are a preliminary estimation of the Company and have not been
audited or reviewed by certified accountants. However, the Company and the external auditor have
preliminarily communicated regarding relevant matters of the performance estimation and have no material
disagreement. These estimations may change as a result of the further processing and analysis of the
financial data that the Company will perform for the preparation of its financial statements, which are
expected to be released after
